Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Dr Milgrom has been on the staff of National Jewish Health (formerly National Jewish Medical and Research Center) in Denver, USA for over 25 years. He holds the appointment of Professor of Pediatrics at the University of Colorado School of Medicine, USA. He treats both adult and pediatric patients who suffer from allergic disorders, chronic cough and vocal cord dysfunction.
Dr Milgrom believes that the greatest challenge for healthcare in the 21st century is to provide effective and cost-effective health management, especially as it pertains to chronic illness. Today's medicine is reactive. In effect, we’re practicing 19th century medicine in the 21st century. We treat the sick – most often empirically with drugs chosen on the basis of common use. In the case of asthma, the patients and we use medications imperfectly resulting in suboptimal outcomes with unnecessary morbidity and cost. Healthcare of the future will be predictive and personalized. Systems medicine will become a major paradigm in clinical research, much as systems biology has become in the natural sciences. It will allow us to target therapy on a personalized basis for those who need it, avoiding treatment for those who do not. The strategy will center on the modern personal health record that provides integrated and comprehensive information as to the health of an individual. New technologies and availability of large databases will profoundly alter the way that outcomes research is conducted and knowledge is conveyed. It appears ever more probable that such information will provide unmatched understanding of a patient's condition, including susceptibility to disease and its progression, as well as the response to treatment. The goal of the right drug for the right patient at the right time just might be attainable.
With the capacity to inject this new intelligence into health delivery, our challenge will be to put the patient first and not to lose track of what it takes to be a good physician. In an increasingly technological age caring and compassion remain foremost in healthcare.
University Professor Ralph Mösges, FAAAAI (MD, PhD) is an otorhinolaryngologist and allergist. He resides in Cologne, Germany. Ralph Mösges is a Professor of Medical Informatics at the Institute of Medical Statistics, Informatics and Epidemiology at the University of Cologne in Germany. He has previously been a Consultant for otorhinolaryngology and responsible for the ORL Allergy Clinic at the University Hospital, Medical Faculty of Aachen, Germany. His current major research fields are allergology, epidemiology, and clinical pharmacology of infectious diseases.
Ralph Mösges is the author and editor of seven books and has published more than 150 articles. Professor Mösges is a member of the German, the European and the American Academies of Allergy and Clinical Immunology, and of the German Academy of Otorhinolaryngology, for which he serves on the guidelines committee.
Alessandro Fiocchi MD is the Director of Allergy at the Pediatric Hospital Bambino Gesù, Rome, Vatican City, Italy. Formerly director of Paediatrics at the Melloni University Hospital in Milan, Italy, he's an expert in the field of food allergy. After post-graduate degrees and professional qualification in paediatrics, allergology, pulmonology, and neonatology, he dedicated his research and clinical work to the care of children with asthma and allergic disease. Currently, he leads a research group focusing on food allergy, asthma, and specific immunotherapy. This group is based in the Bambino Gesù Pediatric Hospital (OPBG) a health care and research institution specialised in paediatric and developing ages. The largest pediatric hospital in Italy, OPBG guarantees total coverage for all health care needs, including allergy.
Since 2001, he has organized international meetings in Milan, Italy, and other countries. He has founded and presides over the Italian Research Foundation for Allergy and Asthma in Childhood – Allegria ONLUS, a charity dedicated to clinical and research studies. As chair of the Adverse Reactions to Foods Committee of the American College of Allergy, Asthma, and Immunology, he co-chaired with Sami Bahna and Amal Assa’ad several International Food Allergy Symposiums, the last in Anaheim, November 2012. He also co-chaired with Hugh Sampson the WAO Food Allergy Symposium in Bangkok, 2007, and in Buenos Aires, 2009. Starting in January 2008, Dr Fiocchi is the chair of the Special Committee on Food Allergy of the World Allergy Organization (WAO). Under his chairmanship, WAO published the DRACMA guidelines on cow's milk allergy in 2010 and the CUPPA position paper on the use of probiotics in pediatric allergy. His publications cover the fields of food allergy diagnosis, follow-up, epidemiology, specific immunotherapy and childhood asthma.
Julie Wang MD is an Assistant Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai in New York, USA. She graduated from the Weill Cornell Medical College in New York City, USA. She completed pediatric residency training at the New York-Presbyterian/Weill Cornell Medical Center in New York, USA and an allergy and immunology fellowship program at the Mount Sinai School of Medicine in New York, USA. She received the American Academy of Allergy, Asthma, and Immunology/Elliot and Roslyn Jaffe Third- Year Fellowship award in 2005.
Dr Wang is an expert in the field of food allergy. Her current research focus is on novel therapeutic approaches to food allergy using Traditional Chinese Medicine; she has been awarded a 5-year National Institutes of Health grant to support this work. Her publications cover the fields of food allergy diagnosis, epidemiology, and therapeutics as well as asthma and food allergy in urban children. Dr Wang is a member of the American Academy of Asthma, Allergy and Immunology, American Academy of Pediatrics, and Society for Pediatric Research.